Pharmacology

• xxx

Adverse Effects

• Interstitial Pulmonary Fibrosis (see Interstitial Lung Disease-Etiology)

References

• Fatal interstitial lung disease associated with oral erlotinib therapy for lung cancer. BMC Cancer. 2007; 7: 150